Figure 2.

(A) Overall incidence of type 2 diabetes among patients in the allopurinol and non-allopurinol groups during study period, (B) Diabetes incidence among patients who were prescribed both allopurinol and colchicine, only allopurinol, only colchicine, and neither medication during the study period, (C) Diabetes incidence for each quartile of duration of allopurinol use among patients in the allopurinol group, (D) Diabetes incidence for each quartile of duration of observation among all patients. ^∗ANOVA analysis across all categories.